Quick answers
- What is Iomeprol injection used for?
- The FDA-approved label (Iomervu, Bracco Diagnostics Inc, February 5, 2026) says: “IOMERVU is a radiographic contrast agent indicated for: Intra-arterial Procedures † Cerebral arteriography, includingintra-arterial digital subtraction angiography (IA-DSA), in adults and pediatric patients Visceral and peripheral arteriography and aortography, including IA-DSA, in adults and pediatric patients Coronary arteriography and cardiac ventriculography in adults Radiographic evaluation of cardiac chambers …” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- Does Iomeprol injection have a boxed warning?
- Yes. The FDA label for Iomervu has a boxed warning (“WARNING: RISKS ASSOCIATED WITH INTRATHECAL ADMINISTRATION”), the FDA’s strongest warning. Read it on the full label and ask your pharmacist.
- Is there a shortage of Iomeprol injection?
- No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
- Has Iomeprol injection been recalled?
- No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
- Who makes Iomeprol injection?
- 1 company lists prescription products of Iomeprol injection in the FDA NDC Directory, including Bracco Diagnostics Inc.
What Iomeprol injection is used for
Quoted from the “Indications and Usage” section of the FDA-approved label.
IOMERVU is a radiographic contrast agent indicated for: Intra-arterial Procedures † Cerebral arteriography, includingintra-arterial digital subtraction angiography (IA-DSA), in adults and pediatric patients Visceral and peripheral arteriography and aortography, including IA-DSA, in adults and pediatric patients Coronary arteriography and cardiac ventriculography in adults Radiographic evaluation of cardiac chambers …
— FDA label: Iomervu, Bracco Diagnostics Inc, effective February 5, 2026. Read the full label on DailyMed →
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
This label has a boxed warning. Its heading: WARNING: RISKS ASSOCIATED WITH INTRATHECAL ADMINISTRATION
. Read it on the full label →
Forms and how it is given
| Dosage forms | Injection, solution |
|---|---|
| Route | Intra-arterial · Intravenous |
| Prescription products | 2 in the FDA NDC Directory |
| Brand names | Iomervu |
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- Bracco Diagnostics Inc2 products
FDA approval history
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Sponsor | Approved | Later changes approved |
|---|---|---|---|
| NDA216016 IOMERVU | Bracco | November 27, 2024 | — |
Shortage status
The FDA drug shortage list does not show these products.
Recalls
No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.
Official identifiers
| SPL set ID of the quoted label | cb2e0e00-7c93-0fb4-89a5-861641662a5a |
|---|---|
| FDA labels (SPL) | 1 |
| FDA applications | NDA216016 |
| Active ingredients (FDA) | IOMEPROL |
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — Iomervu, Bracco Diagnostics Inc, effective February 5, 2026; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →